NCT03827629 - A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 7, 2017

Primary Completion Date

August 16, 2017

Study Completion Date

August 16, 2017

Conditions

Healthy Volunteer

Interventions

DRUG

Treatment A: Naloxone Nasal Spray

Participants received naloxone nasal spray following a 10 hour fast.

DRUG

Treatment B: Naloxone Nasal Spray

Participants received naloxone nasal spray following a 10 hour fast.

DRUG

Treatment C: Naloxone HCL Intramuscular (IM) Injection

Participants received naloxone HCl IM injection following a 10 hour fast.

Trial Locations (1)

Worldwide Clinical Trials, San Antonio